These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
246 related articles for article (PubMed ID: 38244808)
21. Gut microbiome-targeted therapies for Alzheimer's disease. Zhang T; Gao G; Kwok LY; Sun Z Gut Microbes; 2023 Dec; 15(2):2271613. PubMed ID: 37934614 [TBL] [Abstract][Full Text] [Related]
22. How Microbes Affect Depression: Underlying Mechanisms via the Gut-Brain Axis and the Modulating Role of Probiotics. Suda K; Matsuda K Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163104 [TBL] [Abstract][Full Text] [Related]
23. Yun SW; Park HS; Shin YJ; Ma X; Han MJ; Kim DH Nutrients; 2023 Feb; 15(3):. PubMed ID: 36771498 [TBL] [Abstract][Full Text] [Related]
24. Lactobacillus casei improves depression-like behavior in chronic unpredictable mild stress-induced rats by the BDNF-TrkB signal pathway and the intestinal microbiota. Gu F; Wu Y; Liu Y; Dou M; Jiang Y; Liang H Food Funct; 2020 Jul; 11(7):6148-6157. PubMed ID: 32578646 [TBL] [Abstract][Full Text] [Related]
25. Microbiota-Gut-Brain Axis: Pathophysiological Mechanism in Neuropsychiatric Disorders. Shin C; Kim YK Adv Exp Med Biol; 2023; 1411():17-37. PubMed ID: 36949304 [TBL] [Abstract][Full Text] [Related]
26. Probiotics for the treatment of depression and its comorbidities: A systemic review. Gao J; Zhao L; Cheng Y; Lei W; Wang Y; Liu X; Zheng N; Shao L; Chen X; Sun Y; Ling Z; Xu W Front Cell Infect Microbiol; 2023; 13():1167116. PubMed ID: 37139495 [TBL] [Abstract][Full Text] [Related]
27. Ma X; Shin YJ; Park HS; Jeong JW; Kim JY; Shim JJ; Lee JL; Kim DH Nutrients; 2023 May; 15(11):. PubMed ID: 37299451 [TBL] [Abstract][Full Text] [Related]
28. Gut Microbiota and Dysbiosis in Alzheimer's Disease: Implications for Pathogenesis and Treatment. Liu S; Gao J; Zhu M; Liu K; Zhang HL Mol Neurobiol; 2020 Dec; 57(12):5026-5043. PubMed ID: 32829453 [TBL] [Abstract][Full Text] [Related]
29. Emerging role of Gut-microbiota-brain axis in depression and therapeutic implication. Evrensel A; Tarhan KN Prog Neuropsychopharmacol Biol Psychiatry; 2021 Mar; 106():110138. PubMed ID: 33075447 [TBL] [Abstract][Full Text] [Related]
30. Gut microbiota from sigma-1 receptor knockout mice induces depression-like behaviors and modulates the cAMP/CREB/BDNF signaling pathway. Li JH; Liu JL; Li XW; Liu Y; Yang JZ; Chen LJ; Zhang KK; Xie XL; Wang Q Front Microbiol; 2023; 14():1143648. PubMed ID: 37089558 [TBL] [Abstract][Full Text] [Related]
31. Depression and antidepressant effects of ketamine and its metabolites: The pivotal role of gut microbiota. Hua H; Huang C; Liu H; Xu X; Xu X; Wu Z; Liu C; Wang Y; Yang C Neuropharmacology; 2022 Dec; 220():109272. PubMed ID: 36170927 [TBL] [Abstract][Full Text] [Related]
32. Effect of XingPiJieYu decoction on spatial learning and memory and cAMP-PKA-CREB-BDNF pathway in rat model of depression through chronic unpredictable stress. Wang C; Guo J; Guo R BMC Complement Altern Med; 2017 Jan; 17(1):73. PubMed ID: 28118829 [TBL] [Abstract][Full Text] [Related]
33. Lacticaseibacillus rhamnosus TF318 prevents depressive behavior in rats by inhibiting HPA-axis hyperactivity and upregulating BDNF expression. Zhao Y; Kang Y; Zhao Z; Yang G; Gao Y; Gao L; Wang C; Li S Neurosci Lett; 2023 Sep; 814():137460. PubMed ID: 37619699 [TBL] [Abstract][Full Text] [Related]
34. A narrative review of relationship between gut microbiota and neuropsychiatric disorders: mechanisms and clinical application of probiotics and prebiotics. Yang H; Liu Y; Cai R; Li Y; Gu B Ann Palliat Med; 2021 Feb; 10(2):2304-2313. PubMed ID: 33549028 [TBL] [Abstract][Full Text] [Related]
35. Mongolian Medicine Areca Thirteen Pill (GY-13) Improved Depressive Syndrome via upregulating cAMP/PKA/CREB/BDNF signaling pathway. Cai MY; Yang Z; Huang XJ; Li J; Bao WY; Hurilebagen ; Wulanqiqige ; Wuyunsiriguleng ; Cui JW; Ma LQ; Tong HY J Ethnopharmacol; 2022 Jul; 293():115310. PubMed ID: 35452773 [TBL] [Abstract][Full Text] [Related]
36. Obesity and gut-microbiota-brain axis: A narrative review. Asadi A; Shadab Mehr N; Mohamadi MH; Shokri F; Heidary M; Sadeghifard N; Khoshnood S J Clin Lab Anal; 2022 May; 36(5):e24420. PubMed ID: 35421277 [TBL] [Abstract][Full Text] [Related]
37. Gut microbiota-SCFAs-brain axis associated with the antidepressant activity of berberine in CUMS rats. Huang M; He Y; Tian L; Yu L; Cheng Q; Li Z; Gao L; Gao S; Yu C J Affect Disord; 2023 Mar; 325():141-150. PubMed ID: 36610597 [TBL] [Abstract][Full Text] [Related]
38. Rethinking Parkinson Disease: Exploring Gut-Brain Interactions and the Potential Role of Exercise. Zapanta K; Schroeder ET; Fisher BE Phys Ther; 2022 May; 102(5):. PubMed ID: 35225349 [TBL] [Abstract][Full Text] [Related]
39. The Microbiota-Gut-Brain Axis in Neuropsychiatric Disorders: Pathophysiological Mechanisms and Novel Treatments. Kim YK; Shin C Curr Neuropharmacol; 2018; 16(5):559-573. PubMed ID: 28925886 [TBL] [Abstract][Full Text] [Related]
40. Modulating the Microbiota as a Therapeutic Intervention for Type 2 Diabetes. Huda MN; Kim M; Bennett BJ Front Endocrinol (Lausanne); 2021; 12():632335. PubMed ID: 33897618 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]